Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
109888506 | 10988850 | 6 | F | 2000 | 20160812 | 20150405 | 20160817 | EXP | US-JNJFOC-20140915325 | JANSSEN | 0.00 | A | F | Y | 90.72000 | KG | 20160817 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
109888506 | 10988850 | 1 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | Y | N | UNKNOWN;UNKNOWN | 0 | LYOPHILIZED POWDER | |||||||
109888506 | 10988850 | 2 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | Y | N | UNKNOWN;UNKNOWN | 0 | LYOPHILIZED POWDER | |||||||
109888506 | 10988850 | 3 | PS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | Y | N | UNKNOWN;UNKNOWN | 103772 | 600 | MG | LYOPHILIZED POWDER | |||||
109888506 | 10988850 | 4 | C | MOBIC | MELOXICAM | 1 | Oral | 0 | 15 | MG | TABLET | QD | |||||||
109888506 | 10988850 | 5 | C | BENAZEPRIL | BENAZEPRIL HYDROCHLORIDE | 1 | Oral | 5-10 MG | 0 | CAPSULE | |||||||||
109888506 | 10988850 | 6 | C | DRISDOL | ERGOCALCIFEROL | 1 | Oral | 0 | 50000 | IU | TABLET | /wk | |||||||
109888506 | 10988850 | 7 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 0 | 20 | MG | TABLET | QD | |||||||
109888506 | 10988850 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5-10 MG | 0 | CAPSULE | |||||||||
109888506 | 10988850 | 9 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
109888506 | 10988850 | 10 | C | LASIX | FUROSEMIDE | 1 | Oral | 0 | 20 | MG | TABLET | QD | |||||||
109888506 | 10988850 | 11 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 2.5 | MG | TABLET | QD | |||||||
109888506 | 10988850 | 12 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
109888506 | 10988850 | 13 | C | PROLIA | DENOSUMAB | 1 | Subcutaneous | 0 | 60 | MG | SOLUTION | ||||||||
109888506 | 10988850 | 14 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 0 | 1 | MG | TABLET | QD | |||||||
109888506 | 10988850 | 15 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 0 | 2 | MG | TABLET | QD | |||||||
109888506 | 10988850 | 16 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | Oral | 0 | 600 | MG | TABLET | BID | |||||||
109888506 | 10988850 | 17 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | Oral | 0 | 200 | MG | TABLET | BID | |||||||
109888506 | 10988850 | 18 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | 25 | MG | TABLET | QD | |||||||
109888506 | 10988850 | 19 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | 50 | MG | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
109888506 | 10988850 | 1 | Rheumatoid arthritis |
109888506 | 10988850 | 2 | Rheumatoid arthritis |
109888506 | 10988850 | 3 | Rheumatoid arthritis |
109888506 | 10988850 | 4 | Pain |
109888506 | 10988850 | 5 | Blood pressure measurement |
109888506 | 10988850 | 6 | Mineral supplementation |
109888506 | 10988850 | 8 | Blood pressure measurement |
109888506 | 10988850 | 9 | Multiple allergies |
109888506 | 10988850 | 10 | Blood pressure measurement |
109888506 | 10988850 | 11 | Blood cholesterol |
109888506 | 10988850 | 12 | Blood cholesterol |
109888506 | 10988850 | 13 | Bone disorder |
109888506 | 10988850 | 16 | Nutritional supplementation |
109888506 | 10988850 | 17 | Nutritional supplementation |
109888506 | 10988850 | 18 | Blood pressure measurement |
109888506 | 10988850 | 19 | Blood pressure measurement |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
109888506 | 10988850 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
109888506 | 10988850 | Body height decreased | |
109888506 | 10988850 | Decreased activity | |
109888506 | 10988850 | Disability | |
109888506 | 10988850 | Drug ineffective | |
109888506 | 10988850 | Knee arthroplasty | |
109888506 | 10988850 | Malaise | |
109888506 | 10988850 | Off label use | |
109888506 | 10988850 | Product use issue | |
109888506 | 10988850 | Rheumatoid arthritis | |
109888506 | 10988850 | Therapeutic response decreased | |
109888506 | 10988850 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
109888506 | 10988850 | 1 | 200009 | 2008 | 0 | |
109888506 | 10988850 | 2 | 201603 | 0 | ||
109888506 | 10988850 | 3 | 2008 | 20151020 | 0 |